How did the team build the clone?

Verchot's group took a different route. Rather than chasing individual strains, they constructed a DNA copy — known as a cDNA — of the complete genome of a pepper-infecting TSWV isolate. In plain terms, they made a laboratory blueprint of the virus's genetic material.

That blueprint matters because it produces an infectious virus that behaves like the original. With the clone in hand, the team can produce an unlimited amount of virus, inoculate trial plants more efficiently, and help pepper breeders identify superior virus-resistant genetics faster than before.

"Through our research, we can now produce an unlimited amount of virus, more efficiently inoculate trial plants and help pepper breeders move much faster in identifying superior, virus-resistant genetics," Verchot said.

She also pointed to the potential downstream effect for consumers: "By making technology tools that breeders can use to speed new variety development, we hope to see a simple ripple effect where peppers, tomatoes and other produce are more abundant and cost less in grocery stores nationally."

Why does one shared clone help so many researchers?

U.S. researchers have worked on TSWV independently for years, but the virus mutates at a high rate. That means different labs have effectively been studying different strains, making results hard to compare.

"This clone allows all U.S. researchers the same starting point, providing a more efficient tool for identifying the virus in crops and for creating disease management practices," said Haden Ball, Verchot's graduate student, who joined the project as his thesis work.

Having a readily available U.S. clone is critical, the researchers say, for two reasons. First, it lets scientists dissect what drives disease severity and how insects transmit the virus. Second, it gives breeders a standardized tool for developing new resistant varieties.

"We can now pass this technology to plant breeders to create resistant varieties and entomologists to study methods to restrict thrip transmission," Ball said. "Ultimately, we want this discovery to benefit growers and consumers."

What happens next?

The work is already drawing collaborators across disciplines. One is Kevin Crosby, Ph.D., a Texas A&M AgriLife Research vegetable breeder, professor and associate department head for graduate programs in the university's Department of Horticultural Sciences.

Working together, Verchot, Ball, Crosby and other collaborators aim to deliver superior disease-resistant peppers to crop producers first, with additional resistant crops to follow as research progresses.

The technology is not confined to academia. Verchot said it is available for licensing by seed companies, biotech firms and other industry stakeholders.

As with any early-stage research, real-world results will take time. Breeding and releasing a new resistant variety is a multi-year process, and the clone's performance against the emerging strains that escape current plant immunity will need continued testing. Still, the researchers see the clone as a foundational step — one that standardizes the starting material for a national research community that has long lacked it.

If the ripple effect Verchot describes materializes, the beneficiaries would extend beyond laboratory and field. Growers could face fewer losses, and consumers could see more abundant, cheaper peppers and tomatoes in grocery stores nationwide.

Publication details: Haden C. Ball et al., "A Novel Approach to Engineering Tomato Spotted Wilt Virus Infectious Clones by Disarming Key Nodes in Antiviral Defenses," Molecular Plant-Microbe Interactions (2026). DOI: 10.1094/mpmi-12-25-0176-r